Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy

被引:0
|
作者
Stanik, Michal [1 ]
Poprach, Alexander [2 ,3 ]
Littnerova, Simona [4 ]
Capak, Ivo [1 ]
Hulova, Marketa [1 ]
Sebova, Natalia [1 ]
Lakomy, Radek [2 ,3 ]
Jarkovsky, Jiri [4 ]
Dolezel, Jan [1 ]
机构
[1] Masaryk Mem Canc Inst, Dept Urol Oncol, Clin Surg Oncol, Brno, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Comprehens Canc Care, Brno, Czech Republic
[4] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic
关键词
Renal cancer; Nephrectomy; Local neoplasm recurrence; Metastasis; Metastasectomy; CELL CARCINOMA; SURGICAL-TREATMENT; KIDNEY CANCER; LOCAL RECURRENCE; METASTASECTOMY; MANAGEMENT;
D O I
10.1016/j.urolonc.2021.11.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Isolated retroperitoneal recurrence (IRR) in renal cancer patients after radical nephrectomy (RN) is a rare event and poses a therapeutic dilemma. We evaluated oncologic outcomes in surgically treated patients with IRR and established prognostic factors associated with survival. The benefit of metastasis-directed therapy (MDT) in those with clinical progression after extirpation of IRR was assessed. Methods: This was a retrospective single-institutional study in which 60 renal cancer patients after previous RN underwent surgery for suspicion of IRR within the period of 2004-2019; in 55 of them, RCC recurrence was histologically confirmed. No patient had distant metastatic disease at the time of IRR diagnosis. In cases of clinical progression after IRR surgery, MDT (metastasectomy, stereotactic radiotherapy) was selectively used. Kaplan-Meier curves were used to estimate survival outcomes. Univariable and multivariable Cox proportional hazards regression analyses were used to evaluate associations between clinicopathological parameters and cancer-specific survival. Results: Median age at IRR diagnosis was 64 years (range 23-81). IRR was diagnosed at a median of 42 months (IQR 19-99) after RN. Surgical complications of grade 3-5 after IRR extirpation were rare (7%). Median follow-up time was 50 months (IQR 19-80). Five-year recurrence-free survival and cancer-specific survival rates were 32% and 66%, respectively. Radiographic progression was observed in 34 (62%) patients at a median of 11 months after IRR surgery, out of which 22 patients (40%) underwent MDT. When compared with 12 patients without MDT, the MDT patients had a prolonged median time to systemic treatment of 58 (vs. 16 months), and median cancer-specific survival of 88 (vs. 46 months). Upon multivariable analysis, the interval from nephrectomy <= 12 months (HR 7.77), tumour grade 3-4 (HR 13.24) and female sex (HR 7.42) were determined to be independent prognostic factors of cancer-related mortality. Conclusion: Aggressive surgical therapy of IRR is feasible with relatively low morbidity. More than half of the patients experience long-term survival. The interval from nephrectomy to IRR less than 12 months, tumour grade 3-4 and female sex were negative prognostic predictors. In the case of progression, metastasis-directed therapy may prolong the interval to initiation of systemic treatment. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:111.e27 / 111.e34
页数:8
相关论文
共 50 条
  • [21] LONG-TERM ONCOLOGICAL OUTCOMES IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
    Pompe, Raisa
    Gild, Philipp
    Mandel, Philipp
    Chun, Felix
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    JOURNAL OF UROLOGY, 2016, 195 (04): : E858 - E858
  • [22] Surgical management and oncologic outcomes for local recurrence of renal cell carcinoma after radical nephrectomy
    Huang, J.
    Wang, Y.
    Zhang, C.
    Hu, X.
    Wang, P.
    Shi, G.
    Dong, L.
    Zhang, J.
    Kong, W.
    Chen, Y.
    Ye, D.
    Xia, D.
    Guo, J.
    Xue, W.
    Huang, Y.
    He, Z.
    EUROPEAN UROLOGY, 2022, 81 : S580 - S580
  • [23] Outcomes after Radical Nephrectomy for Renal Cell Carcinoma
    Jewett, Michael A. S.
    JOURNAL OF UROLOGY, 2017, 197 (02): : S114 - S115
  • [24] Deleterious Renal Functional Outcomes After Radical Nephrectomy
    Russo, Paul
    EUROPEAN UROLOGY, 2011, 59 (03) : 340 - 341
  • [25] RETROPERITONEAL LYMPHOCYSTS AFTER RADICAL SURGERY IN CERVICAL-CANCER PATIENTS
    DEXTER, LI
    VASILEV, BV
    VOPROSY ONKOLOGII, 1979, 25 (03) : 17 - 20
  • [26] Technical innovation - Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy
    McLaughlin, CA
    Chen, MY
    Torti, FM
    Hall, MC
    Zagoria, RJ
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (01) : 93 - 94
  • [27] Stereotactic Body Radiotherapy in isolated recurrence of pancreatic cancer after radical surgery
    Massaro, M.
    Comito, T.
    Teriaca, M. A.
    Franzese, C.
    Di Cristina, L.
    Marzo, A. M.
    Reggiori, G.
    Gallo, P.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1102 - S1103
  • [28] Management of isolated renal fossa recurrence following radical nephrectomy - Editorial comment
    Russo, P
    JOURNAL OF UROLOGY, 2005, 174 (02): : 477 - 477
  • [29] Bladder recurrence after radical nephroureterectomy: Predictors and impact on oncological outcomes
    Elalouf, Vincent
    Xylinas, Evanguelos
    Klap, Julia
    Pignot, Geraldine
    Delongchamps, Nicolas Barry
    Saighi, Djilali
    Peyromaure, Michael
    Flam, Thierry
    Zerbib, Marc
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (11) : 1078 - 1083
  • [30] ONCOLOGICAL OUTCOMES FOR PARTIAL AND RADICAL NEPHRECTOMY FOR RENAL TUMORS FROM 4 TO 7 CM
    Andreoni, Cassio
    Sepulveda, Fabio
    Pinheiro, Thome
    Salim, Homar
    Tannus, Matheus
    Ortiz, Valdemar
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A184 - A184